Thin
High-Quality Dulaglutide CAS NO:923950-08-7 Pricelist, Service
Request Quote
Select your target sequence below to obtain lot-specific Certificates of Analysis, impurity profiles, and tiered volumetric manufacturer quotes.
The international peptide API manufacturing industry has shifted irrevocably from laboratory bench novelty to high-throughput, precision-engineered industrial chemotype synthesis. Rapid advances in metabolic drug discovery, specifically dual and triple receptor agonists targeting GLP-1, GIP, and Glucagon pathways, require multi-kilogram to metric-ton supplies that maintain analytical purity exceeding 99.0%.
The global dominance of incretin mimetics (Semaglutide, Tirzepatide, Cagrilintide) demands unprecedented scale-up capacity. Chemical synthesis processes must avoid diastereomeric byproducts, handling lipidated side chains and pseudo-proline dipeptide insertions without sacrificing crude purity or downstream chromatography yields.
Cosmetic formulation trends increasingly favor biomimetic peptides, such as Copper Tripeptide (GHK-Cu), for dermal matrix remodeling and wound recovery. Purity thresholds for topical grade peptides have risen dramatically to eliminate trace solvent residues, endotoxins, and trifluoroacetic acid (TFA) salts that cause skin hypersensitivity.
Regulatory authorities in the US and Europe are enforcing stringent environmental limits on traditional coupling solvents like DMF, NMP, and DCM. Progressive CDMOs are implementing sustainable solid-phase peptide synthesis (SPPS) using bio-derived solvents and recycling loops that significantly reduce process mass intensity (PMI).
Procuring pure peptide APIs from contract manufacturers requires technical evaluation beyond unit pricing. Pharmaceutical QA directors, CMC leads, and cosmetic procurement teams must assess sequence verification, counter-ion control, and regulatory compliance before executing supply contracts.
Single-figure purity numbers are insufficient. Rigorous CMC dossiers evaluate peak resolution, identifying deletion sequences (n-1/n+1 mers), truncated peptides, and beta-sheet aggregates via validated reverse-phase ultra-high-performance liquid chromatography.
Peptide salts contain varying amounts of non-peptide components, including bound water and counter-ions (acetate, TFA, or hydrochloride). Procurement specifications must delineate net peptide content via nitrogen analysis or amino acid quantitative analysis.
For parenterally administered compounds such as Vasopressin, Deslorelin, or Dulaglutide, bacterial endotoxin testing via LAL gel-clot or chromogenic methods ensures batch consistency under cGMP conditions.
Lyophilized peptides require validated stability testing under ICH conditions (25°C/60% RH and 40°C/75% RH). Data packages must specify degradation kinetics, deamidation parameters, and recommended cold-chain container integrity.
Hangzhou Thinheal Pharma-Tech Co., Ltd. coordinates synthesis pipelines to mitigate operational risks for generic drug producers, clinical biotechnology innovators, and commercial cosmetic enterprises.
| Domain | Target Molecules | Process Bottlenecks Solved | CMC & Analytical Deliverables |
|---|---|---|---|
| Metabolic GLP-1/GIP Regulators | Semaglutide, Dulaglutide, Tirzepatide, Cargrilintide, Orforglipron | Side-chain acylation efficiency, prevention of aspartimide formation, racemization mitigation in long chains. | Full CoA RP-HPLC chromatograms, LC-HRMS, residual palladium, organic solvent clearance, chiral purity assays. |
| Gastrointestinal Therapeutics | Linaclotide, Teduglutide, GLP-2 Analogues | Complex intramolecular disulfide bond formation (e.g., 3-bridge folding without misfolded topological isomers). | Reg. Dossier Peptide mapping, Ellman's reagent quantification, bioassay potency validation, stability models. |
| Neuroactive & Hormonal Regulators | Semax, Selank, Vasopressin, Deslorelin | Hygroscopicity control, short half-life stability enhancement, trace isomer purification, endotoxin elimination. | USP / EP Compendia Identification via high-resolution MS, elemental CHN analysis, counter-ion stoichiometric verification. |
| Cosmeceuticals & Dermal Actives | GHK-Cu Copper Tripeptide, Acetyl Hexapeptides, Palmitoyl Sequences | Scale manufacturing to metric tons, copper chelation stability, solution discoloration prevention, salt exchange. | Cosmetic Grade Heavy metal analysis, microbiological screening, batch stability profiles, INCI regulatory data. |
Operating from the biomedical cluster at Phase 5, Heda Medicine Valley in Hangzhou, China, our team delivers round-the-clock technical responsiveness and localized supply-chain execution across four global regions.
Coordinated by dedicated technical accounts specializing in FDA IND/NDA filing documentation and EMA GMP compliance. Direct technical desk: [email protected] | WhatsApp: +86 18858158962
Bilingual operational desk supporting regional pharmacopoeial alignment, customized import logistics, and declaration protocols. Direct technical desk: [email protected] | WhatsApp: +86 19956369799
Expedited regional logistics providing seamless delivery to high-volume manufacturing hubs across East and South Asia. Direct technical desk: [email protected] | WhatsApp: +86 13628476528
Focused on regional biopharmaceutical hubs, clinical research consortia, and cosmeceutical compounders. Direct technical desk: [email protected] | WhatsApp: +86 13357150101
Solid-phase peptide synthesis (SPPS) faces yield degradation and solvent accumulation at massive scale. Thinheal's R&D center is leading three technical manufacturing advancements to optimize cost structures and maintain regulatory compliance.
Transitioning step-by-step couplings into automated continuous-flow reactors. This approach eliminates hotspot thermal variations, reduces amino acid excess equivalents, and slashes coupling cycle times from hours to minutes.
For complex peptides exceeding 30–40 amino acids, chemical fragment coupling is paired with engineered peptide ligases. This allows aqueous-phase fragment assembly with precise stereochemical fidelity and zero C-terminal epimerization.
In-line UV-Vis and near-infrared (NIR) monitoring throughout every deprotection and coupling cycle provides real-time verification of resin completeness, ensuring lot-to-lot consistency at the multi-ton level.
Key considerations for global pharmaceutical procurement managers, CMC leaders, and qualified buyers evaluating custom peptide synthesis partnerships.
Explore additional catalog sequences manufactured under controlled quality management systems for research, diagnostic, and commercial applications.
Connect directly with our synthesis chemists and regulatory teams in Hangzhou. Submit your sequence, target purity (>98%, >99%), desired salt profile, and volume requirements to receive analytical validation files and pricing within 24 hours.